Bank of New York Mellon’s Arvinas ARVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Buy
254,997
+18,283
+8% +$171K ﹤0.01% 2919
2026
Q1
$2.51M Sell
236,714
-31,869
-12% -$395K ﹤0.01% 2697
2025
Q4
$3.19M Buy
268,583
+62,896
+31% +$687K ﹤0.01% 2586
2025
Q3
$1.75M Buy
205,687
+5,762
+3% +$43.7K ﹤0.01% 2874
2025
Q2
$1.47M Buy
199,925
+28,611
+17% +$211K ﹤0.01% 2897
2025
Q1
$1.2M Sell
171,314
-4,599
-3% -$72.1K ﹤0.01% 2952
2024
Q4
$3.37M Sell
175,913
-13,891
-7% -$338K ﹤0.01% 2496
2024
Q3
$4.67M Sell
189,804
-45,292
-19% -$1.18M ﹤0.01% 2321
2024
Q2
$6.26M Buy
235,096
+57,835
+33% +$1.84M ﹤0.01% 2213
2024
Q1
$7.32M Sell
177,261
-10,042
-5% -$439K ﹤0.01% 2134
2023
Q4
$7.71M Buy
187,303
+10,059
+6% +$235K ﹤0.01% 2136
2023
Q3
$3.48M Sell
177,244
-646
-0.4% -$15.8K ﹤0.01% 2510
2023
Q2
$4.42M Sell
177,890
-25,769
-13% -$663K ﹤0.01% 2392
2023
Q1
$5.56M Buy
203,659
+1,643
+0.8% +$51.9K ﹤0.01% 2243
2022
Q4
$6.91M Sell
202,016
-1,015
-0.5% -$42.7K ﹤0.01% 2147
2022
Q3
$9.03M Buy
203,031
+18,073
+10% +$877K ﹤0.01% 1955
2022
Q2
$7.79M Sell
184,958
-1,919
-1% -$96.3K ﹤0.01% 2080
2022
Q1
$12.6M Sell
186,877
-13,232
-7% -$902K ﹤0.01% 1952
2021
Q4
$16.4M Buy
200,109
+2,113
+1% +$172K ﹤0.01% 1839
2021
Q3
$16.3M Buy
197,996
+33,055
+20% +$2.92M ﹤0.01% 1836
2021
Q2
$12.7M Buy
164,941
+37,310
+29% +$2.59M ﹤0.01% 1995
2021
Q1
$8.44M Sell
127,631
-15,769
-11% -$1.21M ﹤0.01% 2187
2020
Q4
$12.2M Buy
143,400
+42,728
+42% +$1.47M ﹤0.01% 1903
2020
Q3
$2.38M Buy
100,672
+944
+0.9% +$27.4K ﹤0.01% 2565
2020
Q2
$3.35M Buy
99,728
+20,181
+25% +$857K ﹤0.01% 2413
2020
Q1
$3.21M Buy
79,547
+2,764
+4% +$129K ﹤0.01% 2296
2019
Q4
$3.15M Buy
76,783
+18,932
+33% +$554K ﹤0.01% 2577
2019
Q3
$1.25M Buy
57,851
+1,346
+2% +$33K ﹤0.01% 3039
2019
Q2
$1.24M Buy
56,505
+32,733
+138% +$688K ﹤0.01% 3079
2019
Q1
$351K Buy
+23,772
New +$422K ﹤0.01% 3683

Other funds holding ARVN

Bank of New York Mellon's ARVN Position: Q2 2026 in Review

Bank of New York Mellon increased its Arvinas (ARVN) stake by 7.7% in Q2 2026, buying an estimated $171K and bringing the position to 254,997 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2919.

Bank of New York Mellon first reported a position in ARVN in Q1 2019 and has held it in 30 quarters since. The position peaked at $16.4M in Q4 2021. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Bank of New York Mellon held 254,997 shares of Arvinas worth $2.12M as of Q2 2026.
  • Bank of New York Mellon bought 18,283 Arvinas shares in Q2 2026, an estimated $171K.
  • Arvinas made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2919 holding.
  • Bank of New York Mellon first reported a position in Arvinas in Q1 2019 and has held it in 30 quarters since.
  • Bank of New York Mellon's Arvinas position peaked at $16.4M in Q4 2021.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.